Indira IVF has confidentially filed with SEBI for a ₹3,500 crore IPO through Offer for Sale (OFS).
The IPO involves no fresh shares — only existing shareholders will sell their stake.
EQT, the private equity backer, plans to sell shares worth ₹2,900 crore.
Promoter family members may sell ₹200 crore worth of shares each.
Indira IVF is a market leader in India's fast-growing fertility t
reatment segment.
The global IVF market is expected to reach $13.5 billion by 2034, growing at 16.8%
CAGR.
The IPO provides exposure to India’s underpenetrated fertility healthcare space.
Investment banks like Kotak, IIFL, JPMorgan, and UBS are advising on the issue.
Launch expected in late July or early August 2025, after regulatory approvals.
It's a pure OFS — no dilution — offering liquidity to early investors.